TalkiatryvsCerebral

Talkiatry is a telehealth psychiatry practice, not a medication or device. You complete an online intake about your symptoms, history, and insurance; the platform verifies your coverage and matches you to a licensed, board-certified psychiatrist. You then meet by video for a comprehensive initial evaluation (typically 60-90 minutes), receive a diagnosis and treatment plan, and have shorter follow-up visits for medication management and adjustment. Prescriptions are sent electronically to your pharmacy, and the same psychiatrist provides continuity of care. Therapy is added through your psychiatrist or a Talkiatry therapist referral rather than booked as a standalone service.

Cerebral is not a drug or device; it is a telehealth service that connects you to licensed providers online. After a brief intake assessment, you are matched with a therapist for video or phone sessions using evidence-based methods such as cognitive behavioral therapy (CBT), and/or a prescriber who can evaluate you and prescribe non-controlled psychiatric medications (commonly SSRIs and SNRIs) for conditions like depression and anxiety. The platform handles scheduling, secure messaging, and medication coordination, with prescriptions sent to your pharmacy or shipped. The therapeutic benefit comes from the underlying treatments and the provider relationship, not the app itself.

Talkiatry has not published independent randomized clinical trials of its platform, so its effectiveness is best judged by the model rather than trial data: care is delivered by board-certified psychiatrists using standard, evidence-based psychiatric treatment, and the broader research literature shows telepsychiatry is generally comparable to in-person care for diagnosis and medication management of common conditions like depression and anxiety, with in-person evaluation preferred for higher-acuity or closely monitored cases. Independent reviewers report favorable user-survey results: in HelpGuide's user survey, 90% of surveyed Talkiatry users said they would recommend the service and most reported being satisfied or very satisfied with their care; these are self-reported satisfaction figures, not clinical outcome measures. The most consistent real-world benefit is access: appointments within roughly 1-2 weeks versus traditional psychiatry waits that can stretch 3-6 months in many areas.

There are no clinical trials of Cerebral the company; the relevant evidence is for the treatments it delivers. A 2022 meta-analysis of randomized controlled trials (Giovanetti et al., Telemedicine and e-Health) found video-based psychotherapy essentially equivalent to in-person therapy for depression (Hedges g of about 0.04, i.e., no meaningful difference), with comparable dropout rates. For medication, Cipriani et al.'s 2018 Lancet network meta-analysis of 21 antidepressants found every drug studied was more effective than placebo for acute major depression, with response odds ratios ranging from about 1.37 to 2.13; the broader literature puts the average antidepressant-versus-placebo effect in the modest range (standardized mean difference roughly 0.30). So the modalities Cerebral uses are well supported, while the size of the benefit is moderate and quality depends heavily on your individual provider.

Talkiatry itself is a service, so the medical risks come from the medications its psychiatrists may prescribe. Antidepressants (SSRIs/SNRIs) can cause nausea, insomnia, and sexual side effects, and carry an FDA boxed warning for increased suicidal thoughts and behavior in patients under 25. Stimulants for ADHD can raise heart rate and blood pressure, reduce appetite, disturb sleep, and carry abuse and dependence potential. Mood stabilizers and antipsychotics have their own monitoring needs, sometimes including lab work. Because care is virtual, a limitation is that some conditions ideally warrant in-person evaluation or vital-sign and lab monitoring. Report any new or worsening symptoms to your prescriber, and never rely on Talkiatry for emergencies or suicidal crises (call or text 988, or call 911).

Therapy itself carries little physical risk, though some people feel temporary emotional discomfort discussing difficult topics. The main medical risks come from any prescribed medication. SSRIs and SNRIs commonly cause nausea, headache, insomnia or drowsiness, sexual dysfunction, and weight changes. Serious but less common risks include serotonin syndrome, and antidepressants carry an FDA boxed warning for increased suicidal thoughts and behavior in people under 25, especially early in treatment or after dose changes. Never stop an antidepressant abruptly, as this can cause withdrawal symptoms. Report worsening mood, agitation, or suicidal thoughts to your prescriber immediately, and call or text 988 in a crisis.

As of 2026, Talkiatry is insurance-based with no cash self-pay option. With accepted insurance, the majority of visits cost patients $30 or less out of pocket; depending on your plan, copays or coinsurance commonly run roughly $15-$30 but can be higher (for example $50-$100 or more) before a deductible is met, and the longer initial evaluation may cost more than follow-ups. Talkiatry verifies in-network status before your first appointment and states that if it makes a verification error, it will cover the full cost of that first visit. It does not accept Medicaid; it does accept Original Medicare Part B and select Medicare Advantage plans (coverage varies by state). If your insurance is not accepted, you cannot use Talkiatry, because no out-of-network or self-pay rate is offered.

As of 2026, out-of-pocket prices are roughly $175 per therapy session (with discounted bundles such as about $795 for three months of regular sessions), around $60 per month for medication management (billed about $180 per quarter, with the medication itself extra), roughly $365 per month for combined medication plus therapy, and about $325 per month for couples therapy; veterans may receive a discount. With in-network insurance (Cerebral lists partners such as Aetna, Blue Cross Blue Shield, Cigna, Optum, and UnitedHealthcare), copays average around $30 per session. Prices change frequently, so confirm current rates, your coverage, and your exact copay before starting, since some users have reported surprise charges.

For: insured adults and children age 5 and older with conditions such as depression, anxiety, ADHD, bipolar disorder, OCD, PTSD, or insomnia who want diagnosis and ongoing medication management from a psychiatrist. Requires accepted commercial insurance (for example Aetna, Cigna, UnitedHealthcare/Optum, Blue Cross Blue Shield, and others) or Original Medicare Part B / select Medicare Advantage plans, and residence in a covered state (roughly 43 states as of 2026; accepted plans vary by state). Not for: people who are uninsured or want to pay cash (there is no self-pay option), Medicaid members, those in non-covered states, anyone in crisis or needing emergency, inpatient, or higher-level care, and people seeking standalone talk therapy or treatment for conditions such as severe eating disorders that need in-person care.

Cerebral is designed for US adults 18 and older seeking online therapy or medication management for conditions such as depression, anxiety, insomnia, and bipolar disorder; teen therapy is available in a limited set of states. It is a poor fit for anyone needing controlled substances, including stimulants for ADHD (Adderall, Vyvanse, Ritalin) or benzodiazepines (Xanax), which Cerebral stopped prescribing for most patients in 2022. It is not appropriate for psychiatric emergencies, active suicidal crisis, psychosis, or severe conditions requiring in-person or higher-level care. Anyone in crisis should call or text 988 or go to an emergency room.